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 Introductions: Catheter-related bladder discomfort (CRBD) is common in 
patients with urinary catheterization. Centrally acting intravenous opioid 
like Tramadol inhibits detrusor activity and incidence of CRBD. Present 
study aims to analyze efficacy of intravenous (IV) Tramadol in prevention 
of CRBD in patients undergoing upper urinary tract surgery. 
 
Methods: Adult patients undergoing elective open upper urinary tract 
surgeries at Bir Hospital, National Academy of Medical Sciences (NAMS), 
Nepal, over a period of six months, requiring urinary catheterization were 
randomly divided into Control (C) and Tramadol (T) groups. After general 
anesthesia, patients in T-group received IV Tramadol 1.0 mg/kg and C-
group received normal saline 30 minutes before extubation. In post-
operative ward, CRBD was graded as mild, moderate or severe at 0, 1, 2 
and 6 hours. Post-operative Ramsay sedation score and nausea vomiting 
were compared in two groups.   
 
Results: There were total 70 patients, 35 in each of groups-T and C. 
Incidence of CRBD in T-group was significantly low compared to the C-
group at all points of evaluation (p<0.05). Postoperative sedation score, 
analgesic requirement and nausea vomiting were not significantly 
different in two groups. 
 
Conclusions: Intravenous Tramadol administered before extubation in 
upper urinary tract surgery reduces the incidence of CRBD. 
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Catheter related bladder discomfort (CRBD) is 
a commonly seen problem in the 
postoperative period in catheterized patients. 
Sensation to void and burning sensation in 
urethra are the two most common symptoms 
of CRBD.1 This can lead to exacerbated 
postoperative pain increasing postoperative 
analgesic demand.2  
 
Previous studies have reported the incidence 
of CRBD from 50-90%.1-7 Detrusor smooth 
muscles contraction of bladder is mediated by 
stimulation of the muscarinic receptors.8 So, 
this receptor antagonist such as oxybutynin4 
and tolterodine,2,4 ketamine,5 Gabapentin,6 
Paracetamol7 have been reported to be 
effective in reducing CRBD. Tramadol, a 
centrally acting synthetic opioid analgesic with 
weak opioid agonist properties inhibits 
detrusor activity by inhibiting muscarinic 
receptors. 9-11 Since Tramadol has such unique 
properties and is frequently used in our 
institution as a choice of post-operative 
analgesic, this study was conducted to find out 
its efficacy in preventing CRBD in open upper 





This comparative study was carried out at Bir 
Hospital, National Academy of Medical 
Sciences (NAMS), Nepal, over a period of six 
months from April to September 2011. Study 
was conducted on adult subjects of 18 years of 
age and older of either sex, ASA physical 
status13 I and II, undergoing elective upper 
urinary tract surgery requiring Foleys 
catheterization during surgery. Exclusion 
criteria were obesity (BMI>30), patients with 
bladder outflow obstruction, benign prostatic 
hyperplasia, elderly (age>60), over active 
bladder (urinary frequency >3 times at night 
and >8 times within 24 hours), end stage renal 
disease (urine output <500 ml/24 hours), long 
term opioid use, chronic pain, chronic 
analgesic usage and the subject that could not 
be extubated immediately following surgery.  
As reported incidence of CRBD is up to 90% and 
assuming that Tramadol reduces the incidence 
of CRBD by 30%, with alpha value of 0.05, and 
beta value of 0.8, we would need at least 33 
patients in each group. Total of seventy 
subjects were selected for the study   of two 
equal groups viz group C (Control group) and 
group T (Tramadol group), consisting 35 
subjects each. 
 
After pre-anesthetic check-up, patients were 
explained about the study. Informed written 
consent was obtained. Study subjects were 
pre-medicated with oral diazepam (5 mg for 
patients weighing 50 Kgs and 10 mg for 
patients more than 50 kg), night before 
surgery.  
 
Simple lottery for randomization was used. The 
first patient was assigned C or T as per the slip 
drawn and then alternated subsequently. 
Study medicine was prepared on the day of 
surgery by the anesthetic nurse in identical 5 
ml syringes which could either be 4 ml normal 
saline NS (Group C) or 1.0 mg Tramadol per kg 
body weight diluted in NS to make 4 ml volume 
(Group T). The anesthetic nurse was asked to 
maintain confidentiality and record in a note 
book the study drug to be given to the patient 
according to the randomization in case de-
blinding was necessary. The identity of the 
study drugs was blinded from the patients, the 
primary researcher anesthesiologist, and the 
investigator who collected the postoperative 
data till the data analysis was started.  
 
Intraoperative analgesia was given with 
intravenous Pethidine 0.5 mg/kg. Anesthetic 
induction was done with Propofol 2 mg/kg and 
endotracheal intubation was facilitated with 
Vecuronium Bromide 0.12 mg/kg. Following 
induction of anesthesia, all study subjects were 
catheterized with 16 Fr Foleys catheter on 
properly lubricated urethra with lignocaine 
jelly and its balloon inflated with 10 ml distilled 
water. The catheter was fixed without tension 
and kept on free drain. 
 
Anesthesia was maintained with intermittent 
positive pressure ventilation using 100 % 
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Vecuronium as and when required. Inadequate 
analgesia was defined as an increased systolic 
blood pressure, heart rate or both by at least 
20% of the baseline value for 5 minutes in 
response to surgical stimuli. In cases of 
inadequate analgesia, patients were given 
bolus doses of Pethidine 0.25 mg/kg.  
 
Study medicine as per randomization was 
given IV by an anesthetic registrar on duty 
About 30 min prior to tracheal extubation. 
  
At the time of extubation, all patients received 
a combination of Neostigmine 0.05 mg/kg and 
Atropine 0.02 mg/kg for reversal of muscle 
relaxant and after extubation, were 
transferred to the post anesthetic care unit 
(PACU). At PACU, patients received 
intramuscular Pethidine when needed for 
postoperative pain relief. Another researcher, 
the Surgical registrar, was instructed to watch 
and record incidence and severity of CRBD if 
any, postoperative analgesic requirement, 
postoperative nausea and vomiting (PONV), 
level of sedation, respiratory depression 
immediately after receiving patient (0 hr), and 
thereafter at 1, 2 and 6 hours.  
 
Incidence of CRBD was noted among the 
groups and severity of it was labeled as none 
(patient who did not complain even on asking), 
mild (reported by patients only on 
questioning), moderate (reported by the 
patient on their own) and severe (reported by 
patient on their own accompanied by 
behavioral responses respectively). Behavioral 
response related to CRBD means flailing limb, 
strong vocal response and attempt to pull out 
the catheter.2 
 
The postoperative pain was assessed by VAS, 
scoring from 0 – 100, where 0 means no pain 
and 100 means worst imaginable pain.15 
Postoperative analgesic requirement between 
the groups were noted. 
 
Severity of PONV was graded on a four-point 
ordinal scales from 0 – 3, where, 0, 1, 2, & 3 
mean no, mild, moderate and severe nausea 
+/- vomiting respectively. Inj. Ondansetron 4 
mg IV was given to subject with PONV of grade 
3 only. 
 
The level of sedation was assessed by the 
Ramsay sedation scale17 from 1 to 6, where 
scale of 1 was determined by 
anxious/agitated/restless, 2 co-
operative/oriented/tranquil, 3 respond to 
command/asleep, 4 brisk response to light 
glabellar tap or loud noise, 5 sluggish response 
to light glabellar tap or loud noise and 6 no 
response. Subjects with Ramsay sedation scale 
of 4 or more was considered as sedated. 
 
Respiratory depression was defined as 
ventilatory frequency of less than 8/min 
and/or oxygen saturation of less than 90% with 
oxygen supplementation. 
 
All data were collected and analyzed with one 
way ANOVA, X 2 test, Z- test. SPSS 14.0 was 






Patients in both groups (35 each) were 
comparable, Table 1.  
 
The incidence of CRBD was significantly high in 
control compared to the tramadol group at all 
points 0, 1, 2 and 6 hours evaluation, Table 2. 
 
Postoperative analgesic requirement and 
PONV was not significantly different between 
the two groups. One patient from each group 
complained of mild nausea at 1 hour. 
 
Table 1. Characteristics of surgery patients with Foley catheterization randomized in control group (C) and 
tramadol group (T) to study the incidence of Catheter related bladder discomfort (CRBD)   
 C group: Mean±SD T group: Mean±SD 
Age, (in years) 42.2±11.8 40.9±13.2 
Duration of surgery (in minutes) 55.9±12.3 55.7±12.4 
Duration of Anesthesia (in minutes) 64.9±12.9 64.5±12.1 
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Table 2. Incidence and severity of CRBD in patients with Foley catheter who underwent upper urinary tract 
surgery 
 
Time 0 hour 1 hour 2 hours 6 hours 
Group T C T C T C T C 
Patients (n) 35 35 35 35 35 35 35 35 
CRBD         
None 25 14 24 13 26 16 28 21 
Yes 10* 21 11* 22 9* 19 7* 14 
Mild 6 10 7 11 8 9 6 9 
Moderate 3 8 2 8 1 9 1 7 
Severe 1 3 1 3 0 1 0 1 
*P<0.05 during intergroup comparison. 
 
Table 3. Sedation scores in patients with Foley catheter who underwent upper urinary tract surgery 
 
 
Study groups Ramsay sedation score17 0 Hour 1 Hour 2 Hours 6 Hours 
C (N 35) 
Not Sedated 0 9 14 23 34 
Sedated 
1 5 12 10 1 
2 15 8 1 0 
3 5 1 1 0 
4 1 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
T (N 35) 
Not sedated 0 10 15 24 34 
Sedated 
1 6 8 9 1 
2 13 12 1 0 
3 5 1 1 0 
4 1 0 0 0 
5 0 0 0 0 
6 0 0 0 0 
 
There were no statistical significant differences 
in Ramsay sedation score in two groups. One 
patients from each group had a score of 4 at 0 
hours, and none had score of more than 3 
thereafter, Table 3. None of the patients in 






Our findings show 50% reduction in the 
incidence of CRBD in the Tramadol group and 
none of the subjects were deeply sedated in 
either group, except one in each group 
immediately after extubation. Sedation was 
not associated with any untoward effects and 
also did not hinder in assessing the CRBD at any 
point of the study. This might have been due to 
the lower dose of Tramadol (1 mg/kg) used in 
our study.  
 
Tramadol has central action of opioid analgesic 
and also inhibits the detrusor activity by 
inhibiting type-1 and type-3 muscarinic 
receptors.9,10 Onset of action of tramadol is 
within 10 minutes and peak effect occurs in 
about 30 minutes. 
 
It has been shown that muscarinic receptors 
located in the urothelium/suburothelium and 
on the afferent nerves may contribute to the 
symptoms of CRBD.1-5,12 
 
Pure muscarinic receptor antagonists such as 
tolterodine 2 mg administered 1 hour before 
surgery reduced the incidence of CRBD by 
19%.2 Oxybutinin 5 mg preoperatively has also 
shown to reduce CRBD by 23%.4 However, 
these agents do not have analgesic properties, 
need to be administered orally and have 
undesirable effects as dry mouth, facial 
flushing Intravenous. Paracetamol 15 mg/kg 
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also been shown to reduce the incidence and 
the severity of CRBD.7 However, Paracetamol 
is a drug with proven efficacy for mild to 
moderate post-operative pain only and 
additional analgesics are often required to 
cope with severe postoperative pain. 
 
Since its launch in the UK in 1994, Tramadol 
HCl has been popular for its low adverse 
effects and is used almost as a drug of choice 
for non-steroid anti-inflammatory drugs 
(NSAID) intolerant patients,14-15 the elderly and 
for those undergoing day case surgery.  
 
One study showed the unique property of 
Tramadol beneficial on clinical ground in 
reducing the incidence and severity of CRBD by 
50% along with the reduction in postoperative 
rescue analgesic dose by 20%, when 
administered 1.5 mg/kg IV about 30 minutes 
prior to the end of surgery. This study also 
found a higher incidence of sedation in the 
Tramadol group compared to the control 
group.16 Similar to their study, in our study 
also, we found a 50% reduction in the 
incidence of CRBD in the Tramadol group. 
However, in our study, none of the subjects 
were deeply sedated in either group.  
 
Intravenous tramadol HCl 1.0 mg/kg body 
weight seems to be the ideal drug of choice in 
the prevention of CRBD in postoperative 
patients without high incidence of sedation. 
 
Ketamine, a phencyclidine derivative, which 
binds with N-methyl D-aspertate (NMDA), 
muscarinic and cholinergic receptors also 
reduce the incidence and severity of CRBD.5 
However, a higher incidence of sedation is 
observed even with a subhypnotic dose of 
ketamine. In addition, the significant value of 
minimal respiratory depressant effect of 
Tramadol continues to be emphasized. The 
limitation of our study is that only single dose 
of Tramadol for CRBD has been evaluated. 
Further studies on CRBD by dose response 
titration or continuous therapy of Tramadol in 





Intravenous Tramadol HCL 1.0 mg/kg body 
weight administered about 30 minutes before 
extubation in open upper urinary tract surgery 
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Note from JPAHS editorial- The response from authors for the relevance of publishing the study conducted in 
2011, “there has been lack of publication in regard to similar work in our region, except one published from 
Lucknow, India in 2008 ( https://doi.org/10.1093/bja/aen217)”, the JPAHS editorial believes it is relevant to 
disseminate the important findings for the clinician in local scenario. 
